$Classification of heart failure: A farewell to ejection fraction?$
Código QR

Código QR

Classification of heart failure: A farewell to ejection fraction?

Guardado en:

Detalles Bibliográficos
Autor principal:	Thomas F. Lüscher
Formato:	article
Lenguaje:	EN
Publicado:	KARE Publishing 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/938c85663b8a48f8af8f7a75873791ea
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction
por: Veronika Zach, et al.
Publicado: (2020)

Determinants of gait speed in patients with heart failure with reduced ejection fraction
por: Aylin Tanrıverdi, et al.
Publicado: (2021)

Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
por: M Rizzo, et al.
Publicado: (2020)

Effects of Exercise Training on Cardiac Function in Heart Failure with Preserved Ejection Fraction
por: Hidekatsu Fukuta
Publicado: (2020)

Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition
por: Davide Margonato, et al.
Publicado: (2020)

Transcriptomic Research in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
por: Sebastian Rosch, et al.
Publicado: (2020)

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Sebastiaan HC Klaassen, et al.
Publicado: (2020)

Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
por: Neal M Dixit, et al.
Publicado: (2021)

Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
por: Mauro Gori, et al.
Publicado: (2021)

Mild aortic valve disease and the diastolic pressure–volume relationship in heart failure with preserved ejection fraction
por: Mackram F Eleid, et al.
Publicado: (2021)

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
por: Giuseppe MC Rosano, et al.
Publicado: (2019)

Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction
por: Davide Stolfo, et al.
Publicado: (2019)

Role of nutritional supplementation in heart failure with reduced ejection fraction
por: Yash Paul Sharma, et al.
Publicado: (2021)

Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
por: M Rizzo, et al.
Publicado: (2020)

A profile of heart failure with preserved ejection fraction in a teaching institute
por: Gaurav Aggarwal, et al.
Publicado: (2021)

The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction
por: Osama A. Amin, et al.
Publicado: (2021)

The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
por: Nicholas K Brownell, et al.
Publicado: (2021)

Link Between Synovial and Myocardial Inflammation: Conceptual Framework to Explain the Pathogenesis of Heart Failure with Preserved Ejection Fraction in Patients with Systemic Rheumatic Diseases
por: Milton Packer
Publicado: (2020)

Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study
por: James L Januzzi, et al.
Publicado: (2021)

Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction
por: Ali Çoner, et al.
Publicado: (2021)

Machine learning based diagnosis of heart failure with preserved ejection fraction among South Asian patients
por: Ananya Achanta, et al.
Publicado: (2021)

Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
por: Nancy Luo, MD, MHS, et al.
Publicado: (2021)

Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction
por: Wan Ting Tay, et al.
Publicado: (2021)

The effectiveness and tolerability of switching Indian patients from sacubitril/valsartan, ARNI to perindopril in heart failure with reduced ejection fraction. [Efficient study]
por: Pankaj Jariwala, et al.
Publicado: (2021)

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study
por: Pankaj Jariwala, et al.
Publicado: (2021)

The New Heart Failure Association Definition of Advanced Heart Failure
por: Marco Metra, et al.
Publicado: (2019)

Left ventricular characteristics of noncompaction phenotype patients with good ejection fraction measured with cardiac magnetic resonance
por: Anna Reka Kiss, et al.
Publicado: (2021)

Hyperkalaemia in Heart Failure
por: Umar Ismail, et al.
Publicado: (2021)

Hidden in Heart Failure
por: Douglas Ewan Cannie, et al.
Publicado: (2019)

Ultrafiltration in Acute Heart Failure
por: Maria Rosa Costanzo
Publicado: (2019)

Telemonitoring in Heart Failure Management
por: Ivo Planinc, et al.
Publicado: (2020)

Heart Failure Treatment by Device
por: Antoni Bayés-Genis
Publicado: (2020)

Body Mass Index: An Effective Predictor of Ejection Fraction Improvement in Heart Failure
por: Li-fang Ye, et al.
Publicado: (2021)

Heart Failure and Problems with Frailty Syndrome: Why it is Time to Care About Frailty Syndrome in Heart Failure
por: Izabella Uchmanowicz, et al.
Publicado: (2019)

Pulmonary Embolism and Heart Failure: A Reappraisal
por: Mattia Arrigo, et al.
Publicado: (2021)

Comparison of clinical features and conventional echocardiographic characteristics of patients with heart failure with mid-range ejection fraction with and without interatrial block
por: Ali Çoner
Publicado: (2021)

Comparison of clinical features and conventional echocardiographic characteristics of patients with heart failure with mid-range ejection fraction with and without interatrial block
por: Mustafa Doğduş, et al.
Publicado: (2021)

Is heart failure an obstacle to air travel?
por: Güliz Erdem
Publicado: (2021)

Natriuretic Peptides in Chronic Heart Failure
por: Hans-Peter Brunner-La Rocca, et al.
Publicado: (2019)

Telemonitoring for the Management of Patients with Heart Failure
por: Ferdinando Iellamo, et al.
Publicado: (2020)